• All
• March 28 (Thursday)
• March 29 (Friday)
• March 30 (Saturday)

Day-3 - March 30 (Saturday)

• Functional iron deficiency in cancer patients Ik-Chan Song
  Chungnam National University College of Medicine, Korea CV Abstract
• Assessment of neutropenia in hospitalized patients Young Hoon Park
  Ewha Womans University College of Medicine, Korea CV Abstract
• Perioperative consultation for the appropriate transfusion Ka-Won Kang
  Korea University College of Medicine, Korea CV Abstract

Day-3 - March 30 (Saturday)

• Myeloproliferative neoplasms and inflammation Steffen Koschmieder
  RWTH Aachen University, Germany CV Abstract
• Signaling contributing to the development of myelofibrosis: Beyond JAK/STAT Douglas Tremblay
  Mount Sinai School of Medicine, USA CV Abstract
• Clonal evolution in myelofibrosis Sung-Eun Lee
  The Catholic University of Korea College of Medicine, Korea CV Abstract

Day-3 - March 30 (Saturday)

• Treatment options for relapsed/refractory hodgkin lymphoma after brentuximab vedotin and PD-1 blockade Alex F. Herrera
  City of Hope, USA CV Abstract
• Aggressive B-cell lymphomas: Immuno-chemotherapies other than CAR-T cell therapies Jason Westin
  MD Anderson Cancer Center, USA CV
• Extranodal NK/T cell lymphoma: The immunogenic tumor Won Seog Kim
  Sungkyunkwan University School of Medicine, Korea CV

Day-3 - March 30 (Saturday)

• Genomic technologies for detecting structural variations in hematologic malignancies Miae Jang
  Sungkyunkwan University School of Medicine, Korea CV Abstract
• The role of NGS in hematologic malignancies Young-Uk Cho
  University of Ulsan College of Medicine, Korea CV Abstract
• Germline predisposition to hematologic malignancies Sang Mee Hwang
  Seoul National University College of Medicine, Korea CV Abstract